🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this research study is to evaluate the safety and tolerability ...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2023-04-21
Trial ID
NCT05701488
Treatments Being Tested
Reported in the 2018 NEJM (378; 1277) article, the combination of checkpoin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-08-31
Trial ID
NCT03598816
Treatments Being Tested
The main purpose of this trial is to investigate the effects of a new class...
Status
Completed
Location
Northwestern University
Start Date
2016-11-01
Trial ID
NCT02794883
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of olaparib wh...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2017-06-29
Trial ID
NCT02953457
Treatments Being Tested
This is a Phase 3, multi-national, open-label, 2-arm randomized study in pa...
Status
Completed
Location
Research Site
Start Date
2006-03
Trial ID
NCT00257205
Treatments Being Tested
This is a randomized, open, comparative, multi-centre study which will recr...
Status
Completed
Location
Institut Ste Catherine
Start Date
2017-10-18
Trial ID
NCT03249142
The goal of this Phase 1b clinical trial is to evaluate the safety and effi...
Status
Active Not Recruiting
Location
University of California, San Diego
Start Date
2025-01-03
Trial ID
NCT06710223
Treatments Being Tested
The purpose of this study is to determine if CP-675,206, a monoclonal antib...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00488995
Treatments Being Tested
This is an open-label, multicenter, 2-arm study to evaluate the safety and ...
Status
Completed
Location
Research Facility
Start Date
2017-12-20
Trial ID
NCT03164772
Treatments Being Tested
A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability...
Status
Completed
Location
Research Site
Start Date
2014-05-22
Trial ID
NCT02141347
Treatments Being Tested